Cite
HARVARD Citation
Rotllan, N. et al. (2018). AntimiR-148a Treatment Reduces Atherosclerotic Plaque Formation in Ldlr+/-Apobec1-/-ApoB100TG Mice. Atherosclerosis. pp. 153-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rotllan, N. et al. (2018). AntimiR-148a Treatment Reduces Atherosclerotic Plaque Formation in Ldlr+/-Apobec1-/-ApoB100TG Mice. Atherosclerosis. pp. 153-. [Online].